159 related articles for article (PubMed ID: 10089950)
21. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
Simpson K; Spencer CM; McClellan KJ
Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
[TBL] [Abstract][Full Text] [Related]
22. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
23. An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting.
Olver IN; Craft PS; Clingan PR; Kearsley JH; Planner RS; van Hazel GA; Bell DR; Adena MR; Hall BE; Pearson LL
Med J Aust; 1996 Mar; 164(6):337-40. PubMed ID: 8606657
[TBL] [Abstract][Full Text] [Related]
24. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe B; Hallén C; Frankendal B
Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
[TBL] [Abstract][Full Text] [Related]
25. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
[TBL] [Abstract][Full Text] [Related]
27. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation.
Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A
Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087
[TBL] [Abstract][Full Text] [Related]
28. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
[TBL] [Abstract][Full Text] [Related]
30. Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy.
Hachimi-Idrissi S; De Schepper J; Maurus R; Otten J
Eur J Cancer; 1993; 29A(6):854-6. PubMed ID: 8484976
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.
Wymenga AN; van der Graaf WT; Wils JA; Siegenbeek van Heukelom L; van der Linden GH; Dullemond-Westland AC; Nooy M; van der Heul C; de Bruijn KM; de Vries EG
Ann Oncol; 1996 Jul; 7(5):505-10. PubMed ID: 8839906
[TBL] [Abstract][Full Text] [Related]
32. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
[TBL] [Abstract][Full Text] [Related]
33. Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting.
Münstedt K; Müller H; Blauth-Eckmeyer E; Stenger K; Zygmunt M; Vahrson H
Br J Cancer; 1999 Feb; 79(3-4):637-9. PubMed ID: 10027342
[TBL] [Abstract][Full Text] [Related]
34. Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.
Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
Drugs; 1992; 43 Suppl 3():27-32. PubMed ID: 1380430
[TBL] [Abstract][Full Text] [Related]
35. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Morrow GR; Hickok JT; Rosenthal SN
Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
[TBL] [Abstract][Full Text] [Related]
36. Compassionate use of tropisetron in patients at high risk of severe emesis.
Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
[TBL] [Abstract][Full Text] [Related]
37. On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patients.
Havsteen H; Andersen LJ; Kjaer M; Dalmark M
Anticancer Drugs; 1994 Aug; 5(4):410-8. PubMed ID: 7949244
[TBL] [Abstract][Full Text] [Related]
38. Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.
Van Belle SJ; Stamatakis L; Bleiberg H; Cocquyt VF; Michel J; de Bruijn KM
Ann Oncol; 1994 Nov; 5(9):821-5. PubMed ID: 7848884
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies].
Regidor PA; Nelken B; Regidor M; Bier U; Oberhoff C; Schindler AE
Zentralbl Gynakol; 1996; 118(3):148-53. PubMed ID: 8900604
[TBL] [Abstract][Full Text] [Related]
40. Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments.
Cefalo G; Rottoli L; Armiraglio A; Pagan MG
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):242-5. PubMed ID: 8037343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
